Infinium Global Research Ophthalmic Drugs Market | Page 2

Ophthalmic Drugs Market: Trends and Forecast -2023
The Infinium Global Research analyzes the report of Ophthalmic Drugs Market over
the period of 2017 to 2023. This report also provides detailed qualitative and
quantitative analyses of the market dynamics, market size and future trends in
Global Ophthalmic Drugs Market. It will help a lot of decision makers to develop
strategies and find new opportunities in the Global markets of Ophthalmic Drugs.
The report covers market changing aspects including drivers, restraints,
opportunities, and trends expected to encouragement the expansion of the
Ophthalmic Drugs Market during the said period. The report also provides market
attractiveness analysis, by geography, and market share analysis, by key players
respectively. Some of the prominent participants in the Global Ophthalmic Drugs
Market are Bayer, Valeant Pharmaceuticals, Inc., Pfizer, Inc., Merck & Co., Novartis
AG, Renegeron and Santen Pharmaceuticals Company Ltd. According to report the
global ophthalmic drugs market is projected to grow at a CAGR of 5.4% over the
forecast period of 2017-2023.
For More Details Get Free Few Sample Pages of this Premium Report: -
https://www.infiniumglobalresearch.com/reports/sample-request/165
Ophthalmic drugs are the drugs designed for the treatment of eye diseases and
disorders. This administration of drug can be done by instillation of a cream, an
ointment, or a liquid drop preparation in the conjunctiva SAC. The correct strength
and amount of the drug are selected, and the medication is instilled into the eye or
eyes as directed. The main reason of continuingly strong interest of scientists in
these drugs forms is the problem of a low bioavailability of medicinal substance
after the application to the eyeball. The ability to increase the bioavailability of the
active substances, reducing the susceptibility of drug forms to defense mechanisms
of the human eye, extending contact time of drug with the cornea, increasing the
penetration through the complex anatomical structure of the eye, and providing
controlled release of drugs into the eye tissues which allows reducing the drug
application frequency, witnesses the importance of ophthalmic drugs among the
aging population suffering from eye disorders are some of the factors contributing
to the growth in the global ophthalmic drugs market.
The key factors driving the growth of ophthalmic drugs market are considered to be
increasing geriatric population with rising global population, increase in prevalence
of eye disorders, technological advancement, and increasing awareness in
healthcare spending. Moreover, challenges faced by ophthalmic drugs market
2
© Infinium Global Research